P3 Health Partners (NASDAQ:PIII – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.89) by $1.26, FiscalAI reports. The business had revenue of $386.38 million during the quarter, compared to analyst estimates of $377.80 million.
P3 Health Partners Price Performance
Shares of NASDAQ:PIII traded up $1.25 during midday trading on Monday, hitting $12.83. 366,776 shares of the company’s stock were exchanged, compared to its average volume of 569,755. The stock has a 50 day moving average price of $10.98 and a 200-day moving average price of $6.33. The company has a market cap of $92.95 million, a PE ratio of -0.33 and a beta of 1.63. P3 Health Partners has a 12 month low of $1.52 and a 12 month high of $16.89.
Analyst Ratings Changes
A number of equities research analysts have weighed in on PIII shares. UBS Group set a $14.00 target price on P3 Health Partners in a report on Friday, May 15th. Weiss Ratings upgraded P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 28th. TD Cowen reaffirmed a “hold” rating and set a $14.00 price objective (up from $3.00) on shares of P3 Health Partners in a research report on Friday, May 22nd. Lake Street Capital reiterated a “buy” rating and issued a $14.00 price objective (up from $4.00) on shares of P3 Health Partners in a research note on Friday, May 15th. Finally, Wall Street Zen upgraded shares of P3 Health Partners to a “hold” rating in a research report on Saturday, July 4th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, P3 Health Partners presently has an average rating of “Hold” and an average target price of $14.00.
About P3 Health Partners
P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.
The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.
Featured Articles
- Five stocks we like better than P3 Health Partners
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
